Home/Filings/4/0001209191-17-021403
4//SEC Filing

PharMerica CORP 4

Accession 0001209191-17-021403

CIK 0001388195operating

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:30 PM ET

Size

7.7 KB

Accession

0001209191-17-021403

Insider Transaction Report

Form 4
Period: 2017-03-15
WEISHAR GREGORY S
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2017-03-15$18.48/sh+155,836$2,879,849964,810 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-03-15155,8360 total
    Exercise: $18.48Exp: 2017-03-16Common Stock ($.01 par value ) (155,836 underlying)
Holdings
  • Common Stock, $0.01 par value

    (indirect: By Son)
    1,500
Footnotes (1)
  • [F1]The options vested in the following amounts on the following dates: 38,959 options on 03/16/2011, 38,959 options on 03/16/2012, 38,959 options on 03/16/2013 and 38,959 options on 03/16/2014.

Issuer

PharMerica CORP

CIK 0001388195

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001388195

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:30 PM ET
Size
7.7 KB